Last reviewed · How we verify

NCT06865807

Influence of Suture Type on Emergency Midline Laparotomy Closure

Recruiting now NA Last updated 11 March 2025
What this trial tests

NA trial testing PDS 2/0 vs Monomax 2/0 in Linea Alba Hernia in 100 participants. Currently enrolling.

Timeline
10 February 2025
Primary endpoint
10 February 2026
10 December 2026

Quick facts

Lead sponsorHospital San Juan de Dios Tenerife
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment100
Start date10 February 2025
Primary completion10 February 2026
Estimated completion10 December 2026
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Hospital San Juan de Dios Tenerife

Who can join

18 and older, any sex, with Linea Alba Hernia or Evisceration; Operation Wound. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is no clear recommendation in international guidelines regarding the type of suture to be used for closing emergency midline laparotomies. It is recommended to follow the same principles as in elective surgery, thus performing the closure with a continuous suture of slowly absorbable monofilament 2-0 with small-bites technique. Currently, there are several slowly absorbable sutures available on the market, and our center uses two: PDS® and Monomax®. These two sutures are currently used interchangeably at our institution based on the preferences of each surgeon. Objective: study whether there are differences between these two sutures in the closure of emergency midline laparotomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Hospital San Juan de Dios Tenerife trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06865807.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing